[HTML][HTML] Vitamin D and cardiovascular disease: current evidence and future perspectives

N Cosentino, J Campodonico, V Milazzo, M De Metrio… - Nutrients, 2021 - mdpi.com
Vitamin D deficiency is a prevalent condition, occurring in about 30–50% of the population,
observed across all ethnicities and among all age groups. Besides the established role of …

The benefits of Vitamin D in the COVID-19 pandemic: biochemical and immunological mechanisms

H Musavi, O Abazari, Z Barartabar… - … of physiology and …, 2023 - Taylor & Francis
In December 2019, a new infectious complication called CoronaVirus Infectious Disease-19,
briefly COVID-19, caused by SARS-COV-2, is identified in Wuhan, China. It spread all over …

[HTML][HTML] Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial …

C Cui, P Xu, G Li, Y Qiao, W Han, C Geng, D Liao… - Redox biology, 2019 - Elsevier
Hypertension is one of the major predisposing factors for neurodegenerative disease
characterized with activated renin-angiotensin system (RAS) in both periphery and brain …

[HTML][HTML] FGF23-mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis

I Böckmann, J Lischka, B Richter, J Deppe… - International Journal of …, 2019 - mdpi.com
Patients with chronic kidney disease (CKD) are prone to developing cardiac hypertrophy
and fibrosis, which is associated with increased fibroblast growth factor 23 (FGF23) serum …

Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies

SE Lipshultz, TR Cochran, DA Briston, SR Brown… - Future …, 2013 - Taylor & Francis
Pediatric cardiomyopathies, which are rare but serious disorders of the muscles of the heart,
affect at least one in every 100,000 children in the USA. Approximately 40% of children with …

Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats

M Leifheit-Nestler, A Grabner… - Nephrology Dialysis …, 2017 - academic.oup.com
Background. Vitamin D deficiency and excess of circulating fibroblast growth factor 23
(FGF23) contribute to cardiovascular mortality in patients with chronic kidney disease (CKD) …

Vitamin D receptor: a novel therapeutic target for kidney diseases

S Yang, A Li, JW Wang, J Liu, Y Han… - Current Medicinal …, 2018 - ingentaconnect.com
Background: Kidney disease is a serious problem that adversely affects human health, but
critical knowledge is lacking on how to effectively treat established chronic kidney disease …

Mineral metabolism and cardiovascular disease in CKD

H Fujii, N Joki - Clinical and experimental nephrology, 2017 - Springer
The mineral bone disorder of CKD, called Chronic Kidney Disease-Mineral and Bone
Disorder (CKD-MBD), has a major role in the etiology and progression of cardiovascular …

Cardiac actions of fibroblast growth factor 23

C Faul - Bone, 2017 - Elsevier
Fibroblast growth factors (FGF) are mitogenic signal mediators that induce cell proliferation
and survival. Although cardiac myocytes are post-mitotic, they have been shown to be able …

[HTML][HTML] Vitamin D and its analogues: from differences in molecular mechanisms to potential benefits of adapted use in the treatment of Alzheimer's disease

A Thiel, C Hermanns, AA Lauer, J Reichrath, T Erhardt… - Nutrients, 2023 - mdpi.com
Lifestyle habits and insufficient sunlight exposure lead to a high prevalence of vitamin D
hypovitaminosis, especially in the elderly. Recent studies suggest that in central Europe …